Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Current Deferred Revenue: 2013-2015

Historic Current Deferred Revenue for Tvardi Therapeutics (TVRD) over the last 1 years, with Jun 2015 value amounting to $89,000.

  • Tvardi Therapeutics' Current Deferred Revenue fell 97.10% to $89,000 in Q2 2015 from the same period last year, while for Jun 2015 it was $89,000, marking a year-over-year decrease of 97.10%. This contributed to the annual value of $1.5 million for FY2014, which is 58.22% down from last year.
  • As of Q2 2015, Tvardi Therapeutics' Current Deferred Revenue stood at $89,000, which was down 90.76% from $963,000 recorded in Q1 2015.
  • In the past 5 years, Tvardi Therapeutics' Current Deferred Revenue registered a high of $3.5 million during Q4 2013, and its lowest value of $89,000 during Q2 2015.
  • Over the past 3 years, Tvardi Therapeutics' median Current Deferred Revenue value was $1.9 million (recorded in 2014), while the average stood at $2.1 million.
  • Data for Tvardi Therapeutics' Current Deferred Revenue shows a maximum YoY plummeted of 97.10% (in 2015) over the last 5 years.
  • Over the past 3 years, Tvardi Therapeutics' Current Deferred Revenue (Quarterly) stood at $3.5 million in 2013, then crashed by 58.22% to $1.5 million in 2014, then crashed by 97.10% to $89,000 in 2015.
  • Its Current Deferred Revenue stands at $89,000 for Q2 2015, versus $963,000 for Q1 2015 and $1.5 million for Q4 2014.